Maxigen Biotech Inc.

TWSE:1783 Rapporto sulle azioni

Cap. di mercato: NT$3.7b

Maxigen Biotech Dividendo

Dividendo criteri di controllo 3/6

Maxigen Biotech is a dividend paying company with a current yield of 2.37% that is well covered by earnings.

Informazioni chiave

2.4%

Rendimento del dividendo

-0.2%

Rendimento del riacquisto

Rendimento totale per gli azionisti2.2%
Rendimento futuro dei dividendin/a
Crescita dei dividendi4.7%
Prossima data di pagamento dei dividendin/a
Data di stacco del dividendon/a
Dividendo per azioneNT$0.999
Rapporto di remunerazione60%

Aggiornamenti recenti sui dividendi

Recent updates

Maxigen Biotech's (TWSE:1783) Earnings Are Of Questionable Quality

Mar 28
Maxigen Biotech's (TWSE:1783) Earnings Are Of Questionable Quality

Maxigen Biotech Inc. (TPE:1783) Is Yielding 2.3% - But Is It A Buy?

Apr 22
Maxigen Biotech Inc. (TPE:1783) Is Yielding 2.3% - But Is It A Buy?

We Think You Should Be Aware Of Some Concerning Factors In Maxigen Biotech's (TPE:1783) Earnings

Apr 01
We Think You Should Be Aware Of Some Concerning Factors In Maxigen Biotech's (TPE:1783) Earnings

Maxigen Biotech Inc.'s (TPE:1783) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 16
Maxigen Biotech Inc.'s (TPE:1783) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

The Maxigen Biotech (TPE:1783) Share Price Has Gained 22% And Shareholders Are Hoping For More

Feb 23
The Maxigen Biotech (TPE:1783) Share Price Has Gained 22% And Shareholders Are Hoping For More

Can Maxigen Biotech (TPE:1783) Continue To Grow Its Returns On Capital?

Feb 02
Can Maxigen Biotech (TPE:1783) Continue To Grow Its Returns On Capital?

Tread With Caution Around Maxigen Biotech Inc.'s (TPE:1783) 3.4% Dividend Yield

Jan 10
Tread With Caution Around Maxigen Biotech Inc.'s (TPE:1783) 3.4% Dividend Yield

Declining Stock and Decent Financials: Is The Market Wrong About Maxigen Biotech Inc. (TPE:1783)?

Dec 14
Declining Stock and Decent Financials: Is The Market Wrong About Maxigen Biotech Inc. (TPE:1783)?

If You Had Bought Maxigen Biotech's (TPE:1783) Shares Five Years Ago You Would Be Down 13%

Nov 22
If You Had Bought Maxigen Biotech's (TPE:1783) Shares Five Years Ago You Would Be Down 13%

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: Whilst dividend payments have been stable, 1783 has been paying a dividend for less than 10 years.

Dividendo in crescita: 1783's dividend payments have increased, but the company has only paid a dividend for 7 years.


Rendimento dei dividendi rispetto al mercato

Maxigen Biotech Rendimento dei dividendi rispetto al mercato
Come si colloca il rendimento da dividendo di 1783 rispetto al mercato?
SegmentoRendimento dei dividendi
Azienda (1783)2.4%
Fondo del 25% del mercato (TW)1.7%
Top 25% del mercato (TW)4.4%
Media del settore (Biotechs)2.4%
Analista previsionale (1783) (fino a 3 anni)n/a

Dividendo notevole: 1783's dividend (2.37%) is higher than the bottom 25% of dividend payers in the TW market (1.71%).

Dividendo elevato: 1783's dividend (2.37%) is low compared to the top 25% of dividend payers in the TW market (4.42%).


Distribuzione degli utili agli azionisti

Copertura degli utili: With its reasonable payout ratio (60.4%), 1783's dividend payments are covered by earnings.


Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: With its reasonable cash payout ratio (59.8%), 1783's dividend payments are covered by cash flows.


Scoprire le società che pagano dividendi forti